In summary, this study demonstrated that All-Trans Retinoic Acid (ATRA) treatment significantly reduces the expression of the key stemness markers SOX2 and Nestin in the established glioblastoma cell lines U87-MG and A172, when cultured under neurosphere-promoting conditions. The gene discussed is SOX2; the disease is glioblastoma.